Radiotherapy combined with deep regional hyperthermia in elderly and frail patients with muscle-invasive bladder cancer: quality analysis of hyperthermia and impact on clinical results
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Radiotherapy combined with deep regional hyperthermia in elderly and frail patients with muscle-invasive bladder cancer: quality analysis of hyperthermia and impact on clinical results
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF HYPERTHERMIA
Volume 40, Issue 1, Pages -
Publisher
Informa UK Limited
Online
2023-11-07
DOI
10.1080/02656736.2023.2275540
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
- (2023) Alexandre R Zlotta et al. LANCET ONCOLOGY
- Real World Analysis of Quality of Life and Toxicity in Cancer Patients Treated with Hyperthermia Combined with Radio(chemo)therapy
- (2023) Adela Ademaj et al. Cancers
- Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment
- (2022) Adela Ademaj et al. Cancers
- Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials
- (2021) Ananya Choudhury et al. LANCET ONCOLOGY
- Deep regional hyperthermia with preoperative radiochemotherapy in locally advanced rectal cancer, a prospective phase II trial
- (2021) Cihan Gani et al. RADIOTHERAPY AND ONCOLOGY
- Molecular and biological rationale of hyperthermia as radio- and chemosensitizer
- (2020) A.L. Oei et al. ADVANCED DRUG DELIVERY REVIEWS
- Management of bladder cancer in older patients: Position paper of a SIOG Task Force
- (2020) Nicolas Mottet et al. Journal of Geriatric Oncology
- The Effect of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in 400 Locally Advanced Cervical Carcinoma Patients
- (2019) M. Kroesen et al. Frontiers in Oncology
- Long‐Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High‐Risk Bladder Cancer (Ta, Tis, T1, T2)
- (2019) Ricarda Merten et al. ONCOLOGIST
- A Pilot Study of Radiotherapy and Local Hyperthermia in Elderly Patients With Muscle-Invasive Bladder Cancers Unfit for Definitive Surgery or Chemoradiotherapy
- (2019) Niloy Ranjan Datta et al. Frontiers in Oncology
- Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial
- (2019) Robert A. Huddart et al. EUROPEAN UROLOGY
- Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer
- (2018) Alison Claire Tree et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment
- (2017) Shaista Hafeez et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
- (2017) Vishal Vashistha et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Quality assurance guidelines for superficial hyperthermia clinical trials
- (2017) Hana Dobšíček Trefná et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Radiotherapy for Muscle-invasive Bladder Cancer in Very Elderly Patients
- (2016) TOSHIYA MAEBAYASHI et al. ANTICANCER RESEARCH
- A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer
- (2016) Yoko Harima et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials
- (2015) G. Arcangeli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Trimodal therapy for invasive bladder cancer
- (2015) Romain Mathieu et al. CURRENT OPINION IN UROLOGY
- Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all
- (2015) Arlene L. Oei et al. Radiation Oncology
- Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
- (2014) Guillaume Ploussard et al. EUROPEAN UROLOGY
- Hypofractionated Intensity Modulated Radiation Therapy in Combined Modality Treatment for Bladder Preservation in Elderly Patients With Invasive Bladder Cancer
- (2014) Guy-Anne Turgeon et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Comparison of Radical Cystectomy with Conservative Treatment in Geriatric ( 80) Patients with Muscle-Invasive Bladder Cancer
- (2014) Thomas Martini et al. International Braz J Urol
- Trends in the Utilization of Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Results From the National Cancer Database
- (2013) Harras B. Zaid et al. UROLOGY
- Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
- (2012) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia
- (2012) G. Bruggmoser et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study
- (2010) Rolf D Issels et al. LANCET ONCOLOGY
- Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia
- (2009) Martine Franckena et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started